What is BeatO App?
Founded in 2015 and headquartered in New Delhi, BeatO App has carved out a specialized niche in the digital health ecosystem by integrating hardware and software to simplify diabetes management. The company's flagship offering includes highly portable, smartphone-connected glucometers that provide users with accurate, real-time blood glucose readings. Beyond hardware, the platform serves as a comprehensive health companion, allowing users to track vital metrics such as steps and caloric intake, thereby fostering a holistic approach to wellness. By digitizing the patient experience, BeatO App effectively bridges the gap between clinical diagnostics and daily lifestyle management, positioning itself as a critical tool for the millions of individuals managing chronic conditions in India.
How much funding has BeatO App raised?
BeatO App has raised a total of $38.6M across 2 funding rounds:
Other Financing Round
$5.6M
Series B
$33M
Other Financing Round (2021): $5.6M with participation from W Health Ventures, Leo Capital, Merisis VP, Orios Venture Partners, and Pharmeasy
Series B (2022): $33M led by Flipkart, Lightrock India, and HealthQuad
Key Investors in BeatO App
Flipkart
Flipkart is an India-based e-commerce marketplace offering a broad range of products across categories such as home essentials, electronics, and lifestyle goods, operating as a major online shopping platform.
HealthQuad
HealthQuad is India's leading healthcare innovation fund focused on nurturing models that transform healthcare, emphasizing disease prevention and the use of technology to improve business outcomes.
Leo Capital
Leo Capital is a venture capital fund investing in early-stage, technology-centric opportunities in India, with a focus on large markets where technology creates significant leverage.
What's next for BeatO App?
Looking ahead, the strategic deployment of this capital is expected to focus on scaling the company's digital infrastructure and enhancing its service ecosystem. As BeatO App transitions from a high-growth startup to a more established enterprise-level entity, the focus will likely shift toward deepening its integration with existing healthcare providers and expanding its diagnostic capabilities. The involvement of major strategic partners suggests a roadmap that prioritizes market penetration and the development of a robust, data-driven health platform. By maintaining its focus on user-centric innovation and clinical accuracy, BeatO App is poised to remain at the forefront of the digital health revolution, potentially setting new standards for how chronic diseases are managed in emerging markets.
See full BeatO App company page
